Physician-designed peptide protocols
Adrienne Towsen, MD, is identified as the physician designing, dosing, and monitoring individualized peptide protocols.
Provider source ↗
West Chester, PA · In-person care
Provider overview
Towsen Clinic publishes one West Chester, Pennsylvania office and identifies Adrienne Towsen, MD, a board-certified orthopedic surgeon, as the physician who designs and monitors its peptide and performance protocols. Current materials advertise growth-hormone-related peptides, BPC-157, hormone optimization, medical weight management, and laboratory-guided planning. Several named compounds are investigational, unapproved, compounded, off-label, or unclear in status; this profile records only provider-published availability and makes no conclusion about approval, legality, safety, effectiveness, or eligibility.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Provider-advertised services, grouped for quick scanning with all details visible.
Adrienne Towsen, MD, is identified as the physician designing, dosing, and monitoring individualized peptide protocols.
Provider source ↗The clinic advertises BPC-157 for physician-supervised protocols; the directory does not imply approval, lawful compounding availability, safety, or effectiveness.
Provider source ↗Sermorelin appears in the current growth-hormone-peptide service catalog and requires physician evaluation.
Provider source ↗The official catalog discusses CJC-1295 and ipamorelin; status, formulation, and availability must be confirmed directly.
Provider source ↗The practice advertises individualized hormone assessment and therapy for women and men.
Provider source ↗Physician-led testosterone evaluation and treatment appear in the current hormone service menu.
Provider source ↗The current service catalog includes individualized care for hormonal transitions.
Provider source ↗The clinic lists physician-supervised semaglutide and tirzepatide pathways with metabolic and nutritional support.
Provider source ↗The FAQ describes provider-ordered hormone, thyroid, and metabolic laboratory panels with physician review.
Provider source ↗The practice combines hormone, peptide, movement, and performance-medicine planning for individualized goals.
Provider source ↗Coverage and research
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Evidence
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity current service catalog and location · Checked Jul 28, 2026
Supports: physician identity credentials and clinical model · Checked Jul 28, 2026
Supports: peptide program medical oversight and monitoring · Checked Jul 28, 2026
Supports: named growth hormone related services · Checked Jul 28, 2026
Supports: laboratory testing address phone and email · Checked Jul 28, 2026